Journal
JOURNAL OF THORACIC ONCOLOGY
Volume 13, Issue 10, Pages S494-S494Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jtho.2018.08.637
Keywords
pembrolizumab; EGFR mutation; NSCLC